companies smes start: Live & Latest News Updates : Vimarsana.com
Share this article
Share this article
ResearchAndMarkets.com's offering.
The fertility test market is projected to reach USD 680 Million by 2025 from USD 472 Million in 2020, at a CAGR of 7.5% the forecast period.
Growth in this market is primarily driven by the increasing first-time pregnancy age in women, declining fertility rate among men and women, growing number of women suffering from disorders such as PCOS, emergence of advanced ovulation monitors, and the increased awareness of fertility testing in both developed as well as developing countries.
In terms of Purchase mode, OTC segment to register significant growth during the forecast period..
Based on the mode of purchase, the fertility test market is segmented into direct/prescription, OTC, and online products. In 2020 the OTC segment had the major market share and exhibited high growth. The high growth of this segment is attributed to the inclination of patients towards self-monitoring of healthcare conditions, increasing initiatives by market players to spread awareness on fertility, and the rising preference for confidentiality and accessibility of test results.
JapanUnited-statesIndiaChinaFairhavenNewfoundlandCanadaDublinIrelandSwitzerlandAmericaSwissShare this article
Share this article
ResearchAndMarkets.com's offering.
The Oncology Information Systems Market is Projected to Reach USD 9.5 Billion by 2025 from USD 6.7 Billion in 2020, at a CAGR of 7.4%
Growth of the market is mainly attributed to the technological advancements; increasing incidences of cancer cases, and growing public and private investments, funding, and grants are driving the global oncology information systems market. However, complex regulatory frameworks that delay the approval of new oncology information systems is expected to challenge market growth to a certain extent.
In terms of products, Software segment to register significant growth during the forecast period.
Based on the product, the oncology information systems market is segmented into software, and professional services. Software products include patient information systems, treatment planning systems, and treatment management systems & medical image analysis systems. Significant growth of the orthopedic implants and devices segment is attributed to the ongoing product approval of oncology informatio solutions , increasing agreement between OIS vendors and multinational hospitals for the impementation of oncology information systems , and the increasing availability of these products in major markets. These software allow early recovery of the cancer patients and planned procedure which have led to the growth of this segment.
ChinaJapanUnited-statesIndiaCanadaDublinIrelandAmericaSiemens-healthineersAsia-pacificLaura-woodResearch-facilitiesShare this article
Share this article
ResearchAndMarkets.com's offering.
The foot and ankle devices market is projected to reach USD 5.3 billion by 2025 from USD 3.9 billion in 2020, at a CAGR of 6.4% during the forecast period.
Growth of the market is mainly attributed to the technological advancements; increasing incidences of orthopedic diseases, and growing public and private investments, funding, and grants are driving the global foot and ankle devices market. However, complex regulatory frameworks that delay the approval of new foot and ankle devices is expected to challenge market growth to a certain extent.
In terms of products, orthopedic implants and devices segment to register significant growth during the forecast period.
JapanTennesseeUnited-statesIndiaUnited-kingdomChinaDublinIrelandCanadaAmericaAsia-pacificLaura-wood